## Abstract Postmenopausal hormone therapy (HT) is associated with increased risk of breast cancer. The HTs used in Scandinavia is associated with higher risk estimates than those used in most other countries. Mammographic density is one of the strongest risk factors for breast cancer, and possibly
Hormone therapy use and mammographic density in postmenopausal Norwegian women
β Scribed by Elisabeth Couto; Samera Azeem Qureshi; Solveig Hofvind; Marit Hilsen; Hildegunn Aase; Per Skaane; Lars Vatten; Giske Ursin
- Publisher
- Springer US
- Year
- 2011
- Tongue
- English
- Weight
- 204 KB
- Volume
- 132
- Category
- Article
- ISSN
- 0167-6806
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract The associations between endogenous sex hormone levels and breast cancer risk in postmenopausal women are well established. Mammographic density is a strong risk factor for breast cancer, and possibly an intermediate marker. However, the results from studies on the associations between
## Abstract Birth weight is a significant predictor of breast cancer risk in adult life and mammary gland mass could be an intermediate stage in this long process. We have studied the association of birth size measurements with mammographic density, a marker of mammary gland mass. For a populationβ
## Abstract Mammographic density is a strong risk factor for breast cancer, but the underlying biology for this association is unknown. Studies suggest that vitamin D may reduce breast cancer risk and dietary vitamin D intake has been associated with reduced breast density. We conducted a caseβcont